A detailed history of Vantage Consulting Group Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Vantage Consulting Group Inc holds 1,364 shares of ZTS stock, worth $259,119. This represents 0.39% of its overall portfolio holdings.

Number of Shares
1,364
Previous 1,305 4.52%
Holding current value
$259,119
Previous $220,000 7.27%
% of portfolio
0.39%
Previous 0.32%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $8,586 - $10,550
59 Added 4.52%
1,364 $236,000
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $6,295 - $7,597
38 Added 3.0%
1,305 $220,000
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $2,574 - $3,401
17 Added 1.36%
1,267 $250,000
Q3 2023

Nov 14, 2023

SELL
$167.14 - $192.77 $27,578 - $31,807
-165 Reduced 11.66%
1,250 $217,000
Q2 2023

Aug 11, 2023

SELL
$160.94 - $186.23 $11,426 - $13,222
-71 Reduced 4.78%
1,415 $243,000
Q1 2023

May 10, 2023

SELL
$145.48 - $175.02 $13,675 - $16,451
-94 Reduced 5.95%
1,486 $247,000
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $2,753 - $3,306
21 Added 1.35%
1,580 $231,000
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $10,083 - $12,413
68 Added 4.56%
1,559 $231,000
Q2 2022

Aug 09, 2022

BUY
$155.97 - $200.09 $39,304 - $50,422
252 Added 20.34%
1,491 $256,000
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $20,678 - $26,679
114 Added 10.13%
1,239 $234,000
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $9,684 - $12,351
-50 Reduced 4.26%
1,125 $275,000
Q3 2021

Nov 10, 2021

SELL
$189.29 - $209.69 $12,682 - $14,049
-67 Reduced 5.39%
1,175 $228,000
Q2 2021

Aug 11, 2021

BUY
$155.9 - $187.99 $193,627 - $233,483
1,242 New
1,242 $231,000
Q1 2021

May 14, 2021

SELL
$144.0 - $169.39 $65,376 - $76,903
-454 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $71,309 - $79,154
454 New
454 $75,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $88.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Vantage Consulting Group Inc Portfolio

Follow Vantage Consulting Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Consulting Group Inc with notifications on news.